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Introduction
The purpose of our study is to estimate the frequency of
the histopathological exam, analyze the prognostic/thera-
peutic value of central LN examination and determine
their advantage in elderly patients.
Materials and methods
This retrospective study analyzes 519 patients who were
hospitalized from 1980 to 2008 at the "Istituto di Clinica
Chirurgica" of the University of Trieste and underwent
curative surgery for a sigmoid colon and/or rectum tumor
(minimum follow up period of 4 years): 311 males and
208 females, mean age of 66.95 (range: 17–94 years). 192
patients were younger than 65, 211 were between 65 and
74, 109 between 75 and 84 and 7 older than 84 years.
In cases of complete tumor resection and complete lym-
phadenectomy the surgery was considered as curative. The
tumor was located on sigmoid colon in 147 cases, on rec-
tum in 346 cases (high rectum 101, middle rectum 122
and low rectum 123 cases) and in 26 on both.
372 anterior rectal resections, 20 Hartman's resections, 85
Miles resections and 42 segmental colonic resections were
performed. The choice of the surgical technique, resection
or abdominoperineal amputation, was defined by the
tumor location; stage, dimension and biological charac-
teristics were not taken into account.
In all the cases of subperitoneal tumors we performed a
total mesorectal excision associated with IMA LN dissec-
tion all the way to its origin from the aorta. In 42 cases
among patients with poor general conditions and/or high
operative risk, with the local state of the tumor taken into
account, we performed only a I/II level lymphadenec-
tomy. However, in all the cases, the purpose was to dissect
at least 13 LN, which should represent the cut-off for a
precise staging of the tumor. Those LN are often located in
the proximity of the tumor or along the colon wall. That
is why, in order to retrieve the LN, we opted for examina-
tion of the surgical specimen immediately after the dissec-
tion. LN located less than 5 cm from the tumor were
classified as marginal, those along the branches of the
mesenteric artery or more than 5 cm from the tumor as
intermediate and those at the origin of the IMA as central.
The surgical specimen was then analyzed and the LN are
classified by the pathologist as well.
The Kaplan-Meier actuarial method was used to calculate
the cause-specific survival rate. The Log-rank test was used
to compare the results. The Cox regression was used as a
multivariate analysis. The SPSS software was used for the
statistical procedures.
Results
In 306 cases (59.0%) the LN were retrieved from the sur-
gical specimen and histologically evaluated. In 26 of those
(8.5%) they were metastatic. The retrieval/identification
of the LN was not influenced by the patients' age, with the
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exception of patients older than 84 years. In those patients
the histological determination decreased by 14.3%
(64.6% in the first, 54.5% in the second, 60.65 in the
third, and 14.3% in the fourth age group, p = 0.017).
As regards the location of the tumor the central LN identi-
fication was possible in: 58.5% cases of sigmoid colon
tumor, 60.4% of high rectum tumor, 63.95 of middle rec-
tum tumor, 52% of low rectum tumor and 65.4% syn-
chronous tumors (p = 0.317).
The mortality and morbidity rate among patients in which
the histological evaluation of central LN was possible and
those in which it wasn't were not statistically significant
(the mortality rate was 3.1% and 2.9%, the overall mor-
bidity rate was 38% and 31%, the specific morbidity rate
(fistulae) was 6.8% and 4.9% respectively).
The actuarial survival rate at 5 years was 73.2% in patients
in which the central LN' status was determinated and
62.7% in those in which it wasn't (p = 0.0066). As regards
the stage of the disease the actuarial survival rate was
respectively 85.1% and 82.2% for Dukes A (patients with
central LN' determined status and those in which it was
undetermined), (p = 0.5213), 79.2% and 64.36% for
Dukes B, (p = 0.0123) and 56.1% and 34.7% or Dukes C
(p = 0.0468) patients.
The actuarial survival rate in patients older than 75 years
was 73.4% in those in which the central LN status was
evaluated and 53.57% in those in which it wasn't (p =
0.1122). As regards the number of patients the groups
were comparable:
Dukes A 14 patients each, Dukes B 44 patients in the first
group and 32 in the second, Dukes C 15 patients each (p
= 0.719).
Considering the Dukes stage, the "T" of the tumor, the his-
tological evaluation of the central LN and the grading of
the tumor as independent variables (results that were sta-
tistically significant at the univariate analysis), the Cox
logistic regression assigned an independent value only to
the Dukes stage [Exp (B) 2,082] and the central lymph
node evaluation [Exp (B) 1,402]. The same analysis
applied to the elderly patients assigned an independent
prognostic value to the Dukes stage only.
Conclusion
In our experience, in the cases of sigmoid colon and rec-
tum tumors, the histological evaluation of the central LN
has a precise prognostic value. Patients in which the histo-
logical evaluation of the central LN was performed had a
better prognosis than patients in which the histological
evaluation wasn't possible, considering patients with
tumors in the same stage. In the Dukes A cases the histo-
logical evaluation of the central LN didn't have a prognos-
tic/therapeutic value. The histological evaluation of the
central LN represents the quality standard of the lym-
phadenectomy and ensures a precise staging of the tumor,
which decreases the shifting between tumor stages. From
an oncological point of view the therapeutic improve-
ment achieved can be ascribed to metastatic LN dissec-
tion. The advantage of the precise LN evaluation is
confirmed, although not as statistically significant, even
in the elderly patients. Therefore, we recommend the dis-
section/research of the central LN even in this group of
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